Citrus Health Group and NaviMed Capital Acquire MedLogix Communications

VaLogic Bio (424 Capital) Acquires Facility Logix

September 13, 2024

Healthcare Services

VaLogic Bio, a platform company of private equity firm 424 Capital, has acquired Facility Logix, a Burtonsville, Maryland-based firm specializing in planning, development, and project management for life-sciences facilities. The deal is an add-on acquisition intended to expand VaLogic Bio's service capabilities and build a full-service outsourced solutions platform for life sciences facility design, CQV, environmental monitoring, and ongoing compliance.

Citrus Health Group and NaviMed Capital Acquire Mirador Global, LLC

September 9, 2024

Healthcare Services

Citrus Health Group, together with investor NaviMed Capital, acquired Mirador Global, LLC, a Kennett Square–based commercialization and market access consulting firm. The deal brings Mirador’s launch planning, market access, and commercial strategy expertise into Citrus’s service offering; founder Chuck Peipher will join Citrus’s executive leadership as Chief Strategy Officer while remaining CEO of Mirador Global.

Citrus Health Group and NaviMed Capital Acquire The Curry Rockefeller Group

October 18, 2023

Healthcare Services

Citrus Health Group, together with private investment firm NaviMed Capital, has acquired The Curry Rockefeller Group (CRG), a full-service medical/scientific communications agency based in Tarrytown, New York. CRG's leadership will join the Citrus management team (Jeff Keller named President, Scientific Communications; founders Mike Curry and Chuck Rockefeller to serve as senior advisors) as the agency is integrated into Citrus's healthcare communications platform.

OPEN Health Acquires The CM Group from NaviMed Capital

July 28, 2022

Healthcare Services

OPEN Health has signed a binding agreement to acquire The CM Group, a US-based medical communications platform, from NaviMed Capital. The acquisition expands OPEN Health’s global reach and deepens its scientific communications and market access capabilities for pharmaceutical and biotech clients; terms were not disclosed.

Bioscript Group (backed by Sovereign Capital Partners) Acquires Meridian HealthComms

April 19, 2022

Healthcare Services

Bioscript Group, a Sovereign Capital Partners-backed healthcare communications platform headquartered in Macclesfield, has acquired Meridian HealthComms. The deal is Bioscript's third acquisition since Sovereign backed the management team in March 2021 and expands the group's geographic footprint and service capabilities in medical communications, regulatory writing and market access.

NAMSA (ARCHIMED) Acquires Clinlogix

August 2, 2021

Healthcare Services

Toledo-based NAMSA, a portfolio company of healthcare-focused private equity firm ARCHIMED, has acquired Clinlogix, a Lower Gwynedd, Pennsylvania-based contract research organization (CRO) focused on medical device clinical trials. The deal expands NAMSA's clinical trial capacity by roughly 25%, deepens therapeutic expertise in neurology, oncology, urology and nephrology, and strengthens global trial capabilities with Clinlogix facilities in Japan, Germany and Colombia.